Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-08-01
1981-06-02
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3348, G01T 100, A61K 4300
Patent
active
042711401
ABSTRACT:
The performance of double receptor, specific binding assays is improved by use of a receptor complex having the structure
REFERENCES:
patent: 3646346 (1972-02-01), Catt
patent: 3935074 (1976-01-01), Rubenstein et al.
patent: 4000252 (1976-12-01), Kosak
patent: 4011308 (1977-03-01), Giever
patent: 4020151 (1977-04-01), Bolz et al.
patent: 4041146 (1977-08-01), Giever
patent: 4053284 (1977-10-01), Posch
patent: 4092408 (1978-05-01), Litt
patent: 4108976 (1978-08-01), Reese
patent: 4120945 (1978-10-01), Gutcho et al.
Gurvich et al, 203 (4945): pp. 648-649 (1964).
Vector Laboratories Catalogue, issued about 3/78.
Woodhead et al, Brit. Med. Bull., 30(1), pp. 44-49, 1974.
Heitzmann et al, Proc. Nat. Acad. Sci. USA, 71(9), pp. 3537-3541, (1974).
Cuatrecasas et al, Ann. Rev. Biochem., 406:259, (1971).
Beck et al, Biochem. J., 145 (1975), pp. 607-616.
Baxter Travenol Laboratories Inc.
Flattery Paul C.
Flynn Lawrence W.
Hensley Max D.
Nucker Christine M.
LandOfFree
Method and composition for double receptor, specific binding ass does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for double receptor, specific binding ass, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for double receptor, specific binding ass will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1865025